AMNEAL PHARMACEUTICALS, INC. Dividends Paid
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Dividends Paid of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividends · last filed 2021-03-01
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for the quarter ending 2019-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for the quarter ending 2019-09-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for fiscal 2020 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for fiscal 2018 was $183.00M, a 51.23% decline from fiscal 2017.
- AMNEAL PHARMACEUTICALS, INC. payments of dividends for fiscal 2017 was $375.26M, a 87.06% increase from fiscal 2016.
| Period end | Payments of Dividends 3 month | Payments of Dividends 6 month | Payments of Dividends 9 month | Payments of Dividends 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $153.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $153.00M derived: sum of 3 quarters · filed 2021-03-01 | $183.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $153.00M derived: sum of 2 quarters · filed 2019-11-07 | $183.00M 10-Q · filed 2019-11-07 | $203.00M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $153.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $183.00M 10-Q · filed 2019-08-05 | $203.00M derived: sum of 3 quarters · filed 2020-03-02 | $263.00M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $30.00M 10-Q · filed 2019-05-09 | $50.00M derived: sum of 2 quarters · filed 2020-03-02 | $110.00M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $80.00M derived: sum of 2 quarters · filed 2020-03-02 | $375.26M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $60.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $355.26M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $295.26M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $200.62M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |